Harbin Pharmaceutical Group Acquires GNC Holdings for $1.2 Billion
April 20, 2026
Sycamore Partners has sold GNC Holdings, the distressed vitamin retailer it acquired out of bankruptcy in 2021, to China’s Harbin Pharmaceutical Group for $1.2 billion in cash. The deal is expected to close in Q3 2026, subject to regulatory approval, including CFIUS review.
- Buyers
- Harbin Pharmaceutical Group Co., Ltd.
- Targets
- GNC Holdings
- Sellers
- Sycamore Partners, other minority investors in GNC
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.